封面
市場調查報告書
商品編碼
1633543

心臟輔助設備市場規模、佔有率和成長分析(按產品類型、站點、模式類型和地區)- 產業預測,2025-2032 年

Cardiac Assist Devices Market Size, Share, Growth Analysis, By Product Type (Total Artificial Heart, Intra-Aortic Balloon Pumps ), By Placement Location, By Modality Type, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 241 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年全球心臟輔助設備市場規模價值為 37.4 億美元,預計將從 2024 年的 42.5 億美元成長到 2032 年的 118.8 億美元,預測期內(2025-2032 年)的複合年成長率為 13.7%。

全球心臟輔助裝置市場是醫療設備產業的重要領域,專注於為心臟衰竭和相關心臟疾病的患者提供臨時或長期支援。由於心血管疾病發病率上升和人口老化,對這些醫療設備的需求正在激增。小型化、延長電池壽命和微創植入技術等關鍵進步正在透過提高設備的效率和可近性來推動市場成長。特別是,這個為等待心臟移植或合格接受手術的患者提供替代方案的市場,現有公司與投資創新研發的新參與企業之間的競爭十分激烈。由於技術進步和致力於改善患者治療效果,該領域具有巨大潛力。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 次要和資料資料
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024 年)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 監管格局
  • 案例研究
  • 技術進步

心臟輔助設備市場規模(依產品類型及複合年成長率)(2025-2032)

  • 市場概況
  • 全人工心臟(TAH)
  • 主動脈內球囊幫浦 (IABP)
  • 心室輔助裝置 (VAD)

心臟輔助設備市場規模(依安裝地點分類)及複合年成長率(2025-2032)

  • 市場概況
  • 右心室輔助裝置 (RVAD)
  • 左心室輔助裝置 (LVAD)
  • 體外心室輔助裝置 (VAD)
  • 雙心室輔助裝置 (Bi-VAD)

心臟輔助設備市場規模(按設備類型和複合年成長率) (2025-2032)

  • 市場概況
  • 經皮
  • 嵌入式

心臟輔助設備市場規模(按最終用戶和複合年成長率) (2025-2032)

  • 市場概況
  • 醫院
  • 門診手術中心
  • 其他

心臟輔助設備市場規模(按地區)及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前 5 家公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採用的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024 年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分析市場佔有率
    • 收益與前一年同期比較(2022-2024 年)

主要企業簡介

  • Berlin Heart GmbH(Germany)
  • Biotronik SE & Co. KG(Germany)
  • ReliantHeart Inc.(United States)
  • SynCardia Systems, LLC(United States)
  • Teleflex Incorporated(United States)
  • Levitronix GmbH(Switzerland)
  • Jarvik Heart, Inc.(United States)
  • Sunshine Heart, Inc.(United States)
  • CardiacAssist, Inc.(TandemLife)(United States)
  • CorWave SA(France)
  • Evaheart, Inc.(Japan)
  • FineHeart SA(France)
  • Windmill Cardiovascular Systems, Inc.(United States)
  • CARMAT(France)
  • Calon Cardio-Technology Ltd.(United Kingdom)
  • NewHeart Medical Devices, LLC(United States)
  • MiTiHeart Corporation(United States)
  • CircuLite, Inc.(United States)
  • CardioBridge GmbH(Germany)

結論和建議

簡介目錄
Product Code: SQMIG35A2363

Global Cardiac Assist Devices Market size was valued at USD 3.74 billion in 2023 and is poised to grow from USD 4.25 billion in 2024 to USD 11.88 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).

The global Cardiac Assist Devices market represents a vital segment of the medical device industry, focused on providing temporary or long-term support for patients suffering from heart failure and related cardiac conditions. With the rising prevalence of cardiovascular diseases and a significant aging population, the demand for these devices is surging. Key advancements, including miniaturization, enhanced battery life, and minimally invasive implantation techniques, are fueling market growth by improving device efficiency and accessibility. Notably utilized for patients awaiting heart transplants or as alternatives for those ineligible for surgery, the market features intense competition among established firms and newcomers alike, all investing in innovative R&D. This sector holds substantial potential, driven by technological advancements and a commitment to enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Assist Devices Market Segmental Analysis

Global Cardiac Assist Devices Market is segmented by Product Type, Placement Location, Modality Type, End User and region. Based on Product Type, the market is segmented into Total Artificial Heart (TAH), Intra-Aortic Balloon Pumps (IABP) and Ventricular Assist Devices (VAD). Based on Placement Location, the market is segmented into Right Ventricular Assist Device (RVAD), Left Ventricular Assist Device (LVAD), External Ventricular Assist Device (VAD) and Bi-Ventricular Assist Device (Bi-VAD). Based on Modality Type, the market is segmented into Transcutaneous and Implantable. Based on End User, the market is segmented into Hospital, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Assist Devices Market

A significant driving force behind the global Cardiac Assist Devices market is the escalating prevalence of cardiovascular diseases, particularly coronary artery disease. Factors such as unhealthy dietary habits, sedentary lifestyles, and overall lifestyle modifications are exacerbating the incidence of these conditions worldwide. As cardiovascular diseases become increasingly common, the demand for innovative cardiac assist technologies rises correspondingly, prompting healthcare providers to seek advanced solutions to address this public health crisis. This growing need not only highlights the urgency for effective treatment options but also propels the development and adoption of cardiac assist devices, ultimately shaping the market landscape.

Restraints in the Global Cardiac Assist Devices Market

The global cardiac assist devices market faces several restraints, primarily stemming from technical challenges. Despite the ongoing technological advancements in this field, the effective implantation, management, and monitoring of these devices demand a skilled workforce and specialized infrastructure. The intricacies and steep learning curves involved can hinder healthcare providers' ability to adopt these devices widely. Consequently, this limitation poses a significant barrier to the market's growth, as adequate training and resources are essential to ensure optimal functioning and patient safety. As a result, these technical difficulties may restrict the widespread use of cardiac assist devices within the healthcare system.

Market Trends of the Global Cardiac Assist Devices Market

The Global Cardiac Assist Devices market is witnessing a notable trend towards patient-centric design, reflecting a heightened emphasis on enhancing user experience and overall wellbeing. Manufacturers are increasingly prioritizing innovations that improve comfort and portability by minimizing device size and operational noise, while also addressing complications linked to implantation. This shift not only aims to enhance the quality of life for patients but also encourages patient compliance and satisfaction. As a result, companies are investing in advanced technologies and ergonomic designs, which is anticipated to drive market growth and shape competitive strategies in the evolving landscape of cardiac assist devices.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Cardiac Assist Devices Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Total Artificial Heart (TAH)
  • Intra-Aortic Balloon Pumps (IABP)
  • Ventricular Assist Devices (VAD)

Global Cardiac Assist Devices Market Size by Placement Location & CAGR (2025-2032)

  • Market Overview
  • Right Ventricular Assist Device (RVAD)
  • Left Ventricular Assist Device (LVAD)
  • External Ventricular Assist Device (VAD)
  • Bi-Ventricular Assist Device (Bi-VAD)

Global Cardiac Assist Devices Market Size by Modality Type & CAGR (2025-2032)

  • Market Overview
  • Transcutaneous
  • Implantable

Global Cardiac Assist Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospital
  • Ambulatory Surgical Centers
  • Others

Global Cardiac Assist Devices Market Size & CAGR (2025-2032)

  • North America (Product Type, Placement Location, Modality Type, End User)
    • US
    • Canada
  • Europe (Product Type, Placement Location, Modality Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Placement Location, Modality Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Placement Location, Modality Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Placement Location, Modality Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Berlin Heart GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ReliantHeart Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SynCardia Systems, LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Levitronix GmbH (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jarvik Heart, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sunshine Heart, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardiacAssist, Inc. (TandemLife) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CorWave SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evaheart, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FineHeart SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Windmill Cardiovascular Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARMAT (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Calon Cardio-Technology Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NewHeart Medical Devices, LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MiTiHeart Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CircuLite, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioBridge GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations